Published in Urology on February 13, 2010
Mini incision open pyeloplasty - Improvement in patient outcome. Int Braz J Urol (2015) 1.39
Pyeloplasty techniques using minimally invasive surgery (MIS) in pediatric patients. Transl Pediatr (2016) 0.75
Editorial comment. Urology (2010) 0.75
Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol (2012) 2.85
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Development of a seeded scaffold in the great omentum: feasibility of an in vivo bioreactor for bladder tissue engineering. Eur Urol (2006) 2.17
Perioperative outcomes of robotic-assisted partial nephrectomy in elderly patients: a matched-cohort study. Urology (2012) 2.05
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol (2007) 2.04
Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol (2010) 1.89
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87
Robotic versus laparoscopic partial nephrectomy for complex tumors: comparison of perioperative outcomes. Eur Urol (2012) 1.75
Real-time robotic transrectal ultrasound navigation during robotic radical prostatectomy: initial clinical experience. Urology (2012) 1.62
Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol (2007) 1.60
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res (2005) 1.59
Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients. Urology (2012) 1.50
Seasonality of serum prostate-specific antigen levels: a population-based study. Eur Urol (2006) 1.48
Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment. BJU Int (2010) 1.47
Terminal urothelium differentiation of engineered neoureter after in vivo maturation in the "omental bioreactor". Eur Urol (2007) 1.46
Laparoscopy in ureteral engineering: a feasibility study. Eur Urol (2008) 1.42
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study. Ann Surg Oncol (2011) 1.42
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results. Int J Radiat Oncol Biol Phys (2013) 1.37
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res (2010) 1.31
Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology (2015) 1.23
Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. Cancer Res (2008) 1.23
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther (2008) 1.14
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol (2003) 1.12
Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn (2011) 1.08
Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery. J Urol (2008) 1.08
Congenital pelvic arteriovenous malformation in male patients: a rare cause of urological symptoms and role of embolization. Eur Urol (2002) 1.06
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Res (2009) 1.00
Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. Eur J Cancer (2010) 1.00
Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol (2011) 0.98
Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn (2011) 0.98
First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. Mol Cancer Ther (2012) 0.97
A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol (2002) 0.97
Prostate cancer in renal transplant recipients. Nephrol Dial Transplant (2008) 0.95
Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol (2010) 0.94
Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients. Transplantation (2004) 0.91
Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion. Eur Urol (2004) 0.89
Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int (2013) 0.88
Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial. J Urol (2013) 0.88
Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Curr Mol Pharmacol (2010) 0.88
Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume center experience. Ann Surg Oncol (2012) 0.87
Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation (2003) 0.86
Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS One (2009) 0.86
Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction. Neurourol Urodyn (2011) 0.86
Obturator infected hematoma and urethral erosion following transobturator tape implantation. J Urol (2004) 0.86
Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. Adv Cancer Res (2013) 0.86
Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer. J Urol (2004) 0.85
The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature. Eur Urol (2011) 0.85
[Retroperitoneal laparoscopic nephrectomy fo polycystic kidney: preliminary results]. Prog Urol (2003) 0.84
Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO). Am J Physiol Renal Physiol (2012) 0.84
The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J (2010) 0.84
Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression. Am J Physiol Regul Integr Comp Physiol (2008) 0.83
Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre study. BJU Int (2011) 0.83
Perihepatitis and perinephric abscess due to Mycoplasma hominis in a kidney transplant patient. Exp Clin Transplant (2007) 0.82
High prevalence of erectile dysfunction in young male patients after intramedullary femoral nailing. Urology (2005) 0.81
Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen. Clin Transplant (2013) 0.81
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int (2013) 0.81
[Conservative management of renal haemangioma: value of a synergistic combination of flexible ureteroscopy and CT angiography]. Prog Urol (2007) 0.81
[Retroperitoneal laparoscopic surgery for phaeochromocytoma: analysis of morbidity and haemodynamic instability]. Prog Urol (2007) 0.81
[Treatment of bladder outlet obstruction secondary to suburethral tape by section of the tape]. Prog Urol (2006) 0.80
Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort. World J Urol (2013) 0.79
Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients. Nephrol Dial Transplant (2003) 0.79
[Highlighting differences in the management of neurogenic bladder existing between urologists and physiatrists: A survey conducted among 383 specialists]. Presse Med (2012) 0.79
Fenoterol functionally activates the β₃-adrenoceptor in human urinary bladder, comparison with rat and mouse: implications for drug discovery. Eur J Pharmacol (2012) 0.79
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn (2013) 0.79